Details of study patients and HLA typing
| Patient . | Sex . | Age (y) . | Disease . | Transcript type . | HLA-A type . |
|---|---|---|---|---|---|
| 1 | F | 54 | CML | b3a2 | A2/A3 |
| 2 | M | 47 | CML | b3a2 | A3/A29 |
| 3 | M | 59 | CML | b3a2 | A2/A3 |
| 4 | M | 31 | CML | b2a2 | A1/A3 |
| 5 | M | 49 | CML | b3a2 | A1/A3 |
| 6 | F | 50 | CML | b3a2 | A1/A31 |
| 7 | M | 63 | CML | b2a2 | A23/A31 |
| 8 | M | 39 | CML | b3a2 | A2/A24 |
| 9 | F | 47 | AML | N/A | A2/— |
| 10 | M | 22 | Normal | N/A | A2/A3 |
| 11 | M | 41 | Normal | N/A | A3/— |
| Patient . | Sex . | Age (y) . | Disease . | Transcript type . | HLA-A type . |
|---|---|---|---|---|---|
| 1 | F | 54 | CML | b3a2 | A2/A3 |
| 2 | M | 47 | CML | b3a2 | A3/A29 |
| 3 | M | 59 | CML | b3a2 | A2/A3 |
| 4 | M | 31 | CML | b2a2 | A1/A3 |
| 5 | M | 49 | CML | b3a2 | A1/A3 |
| 6 | F | 50 | CML | b3a2 | A1/A31 |
| 7 | M | 63 | CML | b2a2 | A23/A31 |
| 8 | M | 39 | CML | b3a2 | A2/A24 |
| 9 | F | 47 | AML | N/A | A2/— |
| 10 | M | 22 | Normal | N/A | A2/A3 |
| 11 | M | 41 | Normal | N/A | A3/— |
CML, chronic myeloid leukemia; AML, acute myeloid leukemia; N/A, not applicable.